Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Strahlenther Onkol ; 179(6): 417-22, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12789469

ABSTRACT

PURPOSE: To determine whether dose distribution achieved with treatment plans using high- and low-activity (125)I implants differs. PATIENTS AND METHODS: Based on intraoperative transrectal ultrasound scans of 71 patients, inverse automated treatment plans (IATP) were performed with 15.5-kBq (0.42-mCi) and 25.2-kBq (0.68-mCi) (125)I implants using a commercial 3-D planning system (Variseed). A prescription dose of 145 Gy in 98% of the prostate volume (V100), a maximum dose to the urethra of 250 Gy (D1), and a maximum dose to 10% of the anterior rectal wall of 145 Gy (D10) were required. The plans were manually corrected, if necessary. RESULTS: In the IATP, a better dose coverage of the prostate was found for high-activity seeds (V100 of 98% vs 84%). The prostate dose values increased with the prostate volume. After manual optimization, the differences were only marginal with a prostate V100 of 99% for both activities, a urethra D1 of 247 Gy and 239 Gy, and a rectum D10 of 135 Gy and 124 Gy for high- and low-activity seeds. Low-activity seeds required more sources (66 vs 47) and needles (24 vs 17; all numbers are median values). CONCLUSIONS: Concerning the prostate dose coverage, high-activity seeds are superior in the IATP. After manual adjustment, the dose values for the prostate and the organs at risk are similar. Considering a supposedly decreased toxicity and a shorter implantation time for a lower number of seeds, we recommend high-activity seeds for experienced teams.


Subject(s)
Brachytherapy/methods , Iodine Radioisotopes/therapeutic use , Prostatic Neoplasms/radiotherapy , Radiotherapy Planning, Computer-Assisted/methods , Humans , Male , Prostate/anatomy & histology , Prostatic Neoplasms/diagnostic imaging , Prostatic Neoplasms/surgery , Radiotherapy Dosage , Regression Analysis , Ultrasonography , Urethra/radiation effects
2.
Strahlenther Onkol ; 178(8): 446-52, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12240551

ABSTRACT

AIM: The aim of this study was the validation of the visual image quality of electronic portal imaging devices (EPID) and conventional verification films from the point of view of the end-viewers of portal films, the radiotherapists. MATERIAL AND METHODS: The verification image was represented in two different forms, viz. an electronic portal image employing Siemens Beamview Plus (on a computer monitor) and two different portal films using the conventional verification films CEA-TVS and DuPont CQL-7 (on a negatoscope). A total of 270 image sets (simulation film and portal image) were evaluated by each radiotherapist, evaluation extending to 90 sets of each type of verification film. Each set was evaluated by three specialists in radiotherapy examining subjective visual image quality whereby the following aspects served as evaluation criteria: contrast, artifacts, determination of actual radiation field edge position, anatomical structures and main structural feature for the determination of treatment field position. In addition, the anatomical structures employed for visual feature correlation between reference and portal films were classified according to their importance. RESULTS: In general the electronic portal image was rated significantly "visible" or better. Only the evaluation of artifacts showed an appreciable disadvantage for electronic portal imaging caused by physical artifacts due to radiographic technique and data processing aspects peculiar to the Siemens Beamview Plus 1.1. and also caused by different image processing tools reducing physical artifacts and enhancing the visibility of anatomical structures and likewise of anatomical artifacts (e.g. intestinal gas). By calculating the Spearman correlation coefficient to detect a possible relationship between the different criteria of subjective visual image quality, the research demonstrated that artifacts when limited to a tolerable proportion had no significant impact on the other criteria. CONCLUSIONS: As data of EPIDS are digital, images can be postprocessed and enhanced in a wide variety of ways. Using this tool the electronic portal imaging device provides images that, in terms of visual image quality, are at least comparable to the two evaluated types of radiographic films and also have the added advantage that such images are stored and can be transferred electronically being presupposition for digital patient documentation.


Subject(s)
Diagnostic Imaging/instrumentation , Electronics, Medical , Radiation Oncology/instrumentation , Radiotherapy, Computer-Assisted/instrumentation , Artifacts , Data Interpretation, Statistical , Female , Humans , Image Processing, Computer-Assisted , Male , Neoplasms/radiotherapy , Quality Control , Radiography/instrumentation , Radiotherapy Planning, Computer-Assisted , Radiotherapy, Computer-Assisted/methods , Radiotherapy, Computer-Assisted/standards , Software , Technology, Radiologic , Tomography, X-Ray Computed , X-Ray Film
SELECTION OF CITATIONS
SEARCH DETAIL
...